Contact
Please use this form to send email to PR contact of this press release:
Argos Therapeutics Announces Interim Analysis of Phase 3 ADAPT Trial to be Presented at ESMO 2017 Congress
TO:
Please use this form to send email to PR contact of this press release:
Argos Therapeutics Announces Interim Analysis of Phase 3 ADAPT Trial to be Presented at ESMO 2017 Congress
TO: